INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo CANESTEN®1

SCHEDULING STATUS:
S2

PROPRIETARY NAME
(and dosage form):

CANESTEN®1
Vaginal Tablet

COMPOSITION:
Each vaginal tablet contains
clotrimazole 500 mg

PHARMACOLOGICAL CLASSIFICATION:
A 20.2.2. Fungicides

PHARMACOLOGICAL ACTION:
Clotrimazole has a fungicidal action on Candida species.

INDICATIONS:
For the relief of vaginal itching, burning and discharge associated with recurrent vaginal yeast infections (vaginal candidiasis).

CONTRA-INDICATIONS:
Possible hypersensitivity to clotrimazole.

WARNINGS:
i) Not for oral use.
ii) Use only if you have already had a vaginal yeast infection diagnosed by a medical practitioner and you have the same symptoms now, otherwise consult your doctor. These symptoms include itching and burning of the vagina and sometimes a white discharge.
iii) If there is no improvement in 3 days or if symptoms have not disappeared in 7 days, then consult a medical practitioner as not all vaginal infections are caused by yeasts.
iv) Consult a medical practitioner if you have abdominal pain, fever or a foul-smelling vaginal discharge before or during the use of this medication.
v) If symptoms recur within 2 months, consult a medical practitioner.
vi) If you are pregnant or think you may be pregnant or are nursing, do not use this medication except on the advice of a medical practitioner.
vii) Do not use in girls under 12 years of age, except on the advice of a medical practitioner.
viii) If skin rash or new irritation occurs, discontinue use.
ix) Canesten®1 Vaginal Tablets may reduce the effectiveness and safety of latex products such as condoms and diaphragms. The effect is temporary and occurs only during treatment.

DOSAGE AND DIRECTIONS FOR USE:
In general, a single dose treatment will be sufficient for Candida vaginitis. The CANESTEN 1 Vaginal Tablet should be inserted, preferably at night, into the vagina as deeply as possible (see instructions for use of applicator). This is best achieved when lying back with the legs slightly drawn up. If necessary, a second treatment may be carried out.
It is recommended that the treatment should be timed so as to avoid the menstrual period. For prevention of re-infection the partner should be treated locally with clotrimazole cream at the same time, in as far as symptoms (e.g. pruritus, inflammation, etc.) are present.
In individual cases where disintegration of the tablet does not occur, such as in dry vagina associated with menopause, it is recommended that clotrimazole vaginal cream be used.

SIDE EFFECTS AND SPECIAL PRECAUTIONS:
Local reactions including irritation and burning may occur. Contact allergic dermatitis has been reported. In the case of systemic absorption, lower abdominal cramps, increase in urinary frequency or skin rash may occur. CANESTEN 1 Vaginal Tablet should not be administered to pregnant women during the first trimester, since the safety in this regard has not been established. During pregnancy the CANESTEN 1 Vaginal Tablet 500 mg should be inserted without using an applicator. CANESTEN 1 Vaginal Tablet may only be used during pregnancy on the advice of a medical doctor. The possibility of absorption of clotrimazole when administered vaginally cannot be excluded.
In isolated cases there may be generalised hypersensitivity reactions of varying degrees of severity. These reactions may affect the skin (e.g. itching, redness), breathing (shortness of breath), the circulation (e.g. a drop in blood pressure requiring treatment or even impaired consciousness) or the gastrointestinal tract (e.g.nausea, diarrhoea).

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
See side effects and special precautions. Gastro-intestinal disturbances and central nervous system depression may follow accidental ingestion. Treatment is symptomatic and supportive.

IDENTIFICATION:
White oblong vaginal tablet with the word Bayer on one side and MU on the other side.

PRESENTATION:
Pack containing one vaginal tablet of 500 mg with applicator.

STORAGE INSTRUCTIONS:
Store below 25°C. Keep out of reach of children.

REGISTRATION NUMBER:
Q/20.2.2/281

NAME AND BUSINESS ADDRESS OF THE APPLICANT:
Bayer (Pty) Ltd
Wrench Road        Isando        1600
Reg No 68/11192/07

DATE OF PUBLICATION OF THIS PACKAGE INSERT:
April 1995

® = Registered trade mark of Bayer, Germany

Prior to application remove the tablet from the aluminium foil (as illustrated).

Directions for using the Applicator:
  1. Pull out plunger A until it stops. Place the vaginal tablet into the applicator B.
  2. Insert applicator containing the tablet carefully and as deeply as possible into the vagina (preferably lying on your back).
  3. Push the plunger A until it stops, thereby depositing the tablet into the vagina. Remove the applicator.
Important notice
Pregnant women should follow the instructions of their doctor strictly. During pregnancy insertion should be done without using the applicator.
NB        If the vagina is dry, it is advisable to use the CANESTEN 1 VC Vaginal Cream except in cases of hypersensitivity to cetostearyl alcohol.

ZIMBABWE –PID -88/14.17/1934

Updated on this site: March 2003
Source: Pharmaceutical Industry

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2003